Bicalutamide
CAS 90357-06-5 26 FDA-DMF suppliersSmall Molecule
Overview
Bicalutamide is a non-steroidal antiandrogen medication used primarily to treat prostate cancer. It works by inhibiting the action of male hormones in the prostate, slowing the growth of prostate cancer cells.
API suppliers (28)
Suppliers of Bicalutamide backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- TAPI NL BV1 active DMF
- TAPI NL BV1 active DMF
- UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)Spain1 active DMF
- SHILPA PHARMA LIFESCIENCES LTD1 active DMF
- ARCH PHARMALABS LTD1 active DMF
- ARCH PHARMALABS LTD1 active DMF
- TAPI NL BV1 active DMF
- Sun Pharmaceutical Industries LimitedIndia1 active DMF
- ARCH PHARMALABS LTD1 active DMF
- UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)Spain1 active DMF
- SHILPA PHARMA LIFESCIENCES LTD1 active DMF
- KEKULE PHARMA LTDIndia
- MYLAN LABORATORIES LTD
- GENESEN LABS LTD
- Emcure Pharmaceuticals LimitedIndia
- Arevipharma GmbHGermany
- SIGNA SA DE CV
- Zhejiang Hisun Pharmaceutical Co., Ltd.China
- GNT Pharma Co., Ltd.South Korea
- USV PRIVATE LTD
- Cipla USA, Inc.USA
- EXCELLA GMBH
- COSMA SPAItaly
- TAI HENG INDUSTRY CO LTD
- Lupin LimitedIndia
Showing 25 of 28 suppliers — see the full list in the app.
Therapeutic areas
OncologyEndocrinology
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.